Sleep-related movement disorders

CONTINUUM Lifelong Learning in Neurology

Volumn 19, Issue 1, 2013, Pages 170-184

  Silber, Michael H ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; CARBIDOPA; CLONAZEPAM; CODEINE; FERROUS GLUCONATE; FERROUS SULFATE; GABAPENTIN; GABAPENTIN ENACARBIL; LEVODOPA; METHADONE; OXYCODONE; PRAMIPEXOLE; PREGABALIN; ROPINIROLE; ROTIGOTINE; TEMAZEPAM; TRAMADOL; ZOLPIDEM;

AMNESIA; BLOOD BRAIN BARRIER; BRUXISM; COGNITIVE DEFECT; CONSTIPATION; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DIZZINESS; DOWN REGULATION; ELECTROMYOGRAPHY; HUMAN; HYPERSOMNIA; IMPULSE CONTROL DISORDER; IRON TRANSPORT; LEG CRAMP; MOTOR DYSFUNCTION; NAUSEA; PATHOPHYSIOLOGY; PERIODIC LIMB MOVEMENT DISORDER; POLYSOMNOGRAPHY; PREVALENCE; PRURITUS; QUALITY OF LIFE; RESTLESS LEGS SYNDROME; REVIEW; RHYTHMIC MOVEMENT DISORDER; SEIZURE; SIDE EFFECT; SLEEP DISORDERED BREATHING; SLEEP EATING; SLEEP RELATED BRUXISM; SLEEP RELATED MOVEMENT DISORDER; SLEEP WALKING; UNSTEADINESS; WEIGHT GAIN; WILLIS EKBOM DISEASE;

AGED; CALCIUM CHANNEL BLOCKERS; FEMALE; HUMANS; MALE; MIDDLE AGED; MOVEMENT DISORDERS; NOCTURNAL MYOCLONUS SYNDROME; RECEPTORS, DOPAMINE D2; RESTLESS LEGS SYNDROME; SLEEP BRUXISM; SLEEP DISORDERS; SLEEP-WAKE TRANSITION DISORDERS;

EID: 84873650398     PISSN: 10802371     EISSN: 15386899     Source Type: Journal    
DOI: 10.1212/01.CON.0000427207.13553.68     Document Type: Review

References (46)

1. Ekbom KA. Restless legs. Stockholm, Sweden: Ivar Hoeggstroms; 1945.
2. Allen R, Bharmal M, Calloway M. Prevalence and disease burden of primary restless legs syndrome: results of a general population survey in the United States. Mov Disord 2011;26(1):114-120.
3. Allen RP, Stillman P, Myers AJ. Physician-diagnosed restless legs syndrome in a large sample of primary medical care patients in western Europe: prevalence and characteristics. Sleep Med 2010;11(1):31-37.
4. American Academy of Sleep Medicine. International classification of sleep disorders: diagnostic and coding manual. 2nd ed. Westchester, IL: American Academy of Sleep Medicine, 2005.
5. Allen RP, Picchietti D, Hening WA, et al. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 2003;4(2):101-119. (Pubitemid 36527231)
6. Hening WA, Allen RP, Washburn M, et al. The four diagnostic criteria for restless legs syndrome are unable to exclude confounding conditions ("mimics"). Sleep Med 2009;10(9):976-981.
7. Allen RP, Burchell BJ, MacDonald B, et al. Validation of the self-completed Cambridge-Hopkins questionnaire (CH-RLSq) for ascertainment of restless legs syndrome (RLS) in a population survey. Sleep Med 2009;10(10):1097-1100.
8. Trenkwalder C, Hogl B, Winkelmann J. Recent advances in the diagnosis, genetics and treatment of restless legs syndrome. J Neurol 2009;256(4):539-553.
9. Connor JR, Boyer PJ, Menzies SL, et al. Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome. Neurology 2003;61(3):304-309. (Pubitemid 36975956)
10. Schmidauer C, Sojer M, Seppi K, et al. Transcranial ultrasound shows nigral hypoechogenicity in restless legs syndrome. Ann Neurol 2005;58(4):630-634. (Pubitemid 41377229)
11. Connor JR, Ponnuru P, Wang X-S, et al. Profile of altered brain iron acquisition in restless legs syndrome. Brain 2011;134(pt 4): 959-968.
12. Connor JR, Wang X-S, Allen RP, et al. Altered dopaminergic profile in the putamen and substantia nigra in restless leg syndrome. Brain 2009;132(pt 9):2403-2412.
13. Earley C, Silber MH. Restless legs syndrome: understanding its consequences and the need for better treatment. Sleep Med 2010;11(9):807-815.
14. Innes KE, Selfe TK, Agarwal P. Restless legs syndrome and conditions associated with metabolic dysregulation, sympathoadrenal dysfunction, and cardiovascular disease risk: a systematic review. Sleep Med Rev 2012; 16(4):309-339.
15. Montplaisir J, Boucher S, Poirier G, et al. Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: a study of 133 patients diagnosed with new standard criteria. Mov Disord 1997;12(1): 61-65. (Pubitemid 27032881)
16. Earley CJ, Horska A, Mohamed MA, et al. A randomized, double-blind, placebo-controlled trial of intravenous iron sucrose in restless legs syndrome. Sleep Med 2009;10(2):206-211.
17. Grote L, Leissner L, Hedner J, Ulfberg J. A randomized, double-blind, placebo controlled, multi-center study of intravenous iron sucrose and placebo in the treatment of restless legs syndrome. Mov Disord 2009; 24(10):1445-1452.
18. Allen RP, Adler CH, Du W, et al. Clinical efficacy and safety of IV ferric carboxymaltose (FCM) treatment of RLS: a multi-centred, placebo-controlled preliminary clinical trial. Sleep Med 2011; 12(9):906-913.
19. García-Borreguero D, Williams A. Dopaminergic augmentation of restless legs syndrome. Sleep Med Rev 2010;14(5):339-346.
20. Lipford MC, Silber MH. Long-term use of pramipexole in the mangement of restless legs syndrome. Sleep 2011;34:A202.
21. Silver N, Allen RP, Senerth J, Earley CJ. A 10-year, longitudinal assessment of dopamine agonists and methadone in the treatment of restless legs syndrome. Sleep Med 2011;12(5):440-444.
22. Cornelius JR, Tippmann-Peikert M, Slocumb NL, et al. Impulse control disorders with the use of dopaminergic agents in restless legs syndrome: a case-control study. Sleep 2010;33(1):81-87.
23. Ondo WG, Lai D. Predictors of impulsivity and reward seeking behavior with dopamine agonists. Parkinsonism Relat Disord 2008;14(1):28-32.
24. Pourcher E, Remillard S, Cohen H. Compulsive habits in restless legs syndrome patients under dopaminergic treatment. J Neurol Sci 2010;290(1-2):52-56.
25. Voon V, Schoerling A, Wenzel S, et al. Frequency of impulse control behaviours associated with dopaminergic therapy in restless legs syndrome. BMC Neurol 2011; 11:117.
26. Hogl B, Garcia-Borreguero D, Kohnen R, et al. Progressive development of augmentation during long-term treatment with levodopa in restless legs syndrome: results of a prospective multi-center study. J Neurol 2010;257(2):230-237.
27. Garcia-Borreguero D, Larrosa E, De la Llave Y, et al. Treatment of restless legs syndrome with gabapentin: a double-blind, cross-over study. Neurology 2002;59(10):1573-1579. (Pubitemid 35387065)
28. Garcia-Borreguero D, Larrosa O, Williams AM, et al. Treatment of restless legs syndrome with pregabalin: a double-blind, placebo-controlled study. Neurology 2010; 74(23):1897-1904.
29. Lee DO, Ziman RB, Perkins AT, et al. A randomized, double-blind, placebo-controlled study to assess the efficacy and tolerability of gabapentin enacarbil in subjects with restless legs syndrome. J Clin Sleep Med 2011;7(3):282-292.
30. Silber MH. Movement disorders and parasomnias. In: Krahn LE, Silber MH, Morgenthaler TI, eds. Atlas of sleep medicine. London, UK: Informa Healthcare; 2011:117-130.
31. Wetter TC, Collado-Seidel V, Pollmacher T, et al. Sleep and periodic leg movement patterns in drug-free patients with Parkinson's disease and multiple system atrophy. Sleep 2000;23(3):361-367. (Pubitemid 30263169)
32. Bixler EO. Nocturnal myoclonus and nocturnal myoclonic activity in the normal population. Res Commun Chem Pathol Pharmacol 1982;36(1):129-140. (Pubitemid 12107564)
33. Ancoli-Israel S, Kripke DF, Klauber MR, et al. Periodic limb movements in sleep in community-dwelling elderly. Sleep 1991; 14(6):496-500.
34. Dickel MJ, Mosko SS. Morbidity cut-offs for sleep apnea and periodic leg movements in predicting subjective complaints in seniors. Sleep 1990;13(2):155-166. (Pubitemid 20112676)
35. Mendelson W. Are periodic limb movements associated with clinical sleep disturbance? Sleep 1996;19(3):219-223. (Pubitemid 26138227)
36. Youngstedt SW, Kripke DF, Klauber MR, et al. Periodic leg movements during sleep and sleep disturbances in elders. J Gerontol A Biol Sci Med Sci 1998;53(5):M391-M394. (Pubitemid 29010747)
37. Carrier J, Frenette S, Montplaisir J, et al. Effects of periodic leg movements during sleep in middle-aged subjects without sleep complaints. Mov Disord 2005;20(9): 1127-1132. (Pubitemid 41632199)
38. Karadeniz D, Ondze B, Besset A, Billiard M. EEG arousals and awakenings in relation with periodic leg movements during sleep. J Sleep Res 2000;9(3):273-277.
39. Montplaisir J, Boucher S, Gosselin A, et al. Persistence of repetitive EEG arousals (K-alpha complexes) in RLS patients treated with L-dopa. Sleep 1996;19(3):196-199. (Pubitemid 26138223)
40. Pennestri MH, Montplaisir J, Colombo R, et al. Nocturnal blood pressure changes in patients with restless legs syndrome. Neurology 2007;68(15):1213- 1218. (Pubitemid 46608469)
41. Siddiqui F, Strus J, Ming X, et al. Rise of blood pressure with periodic limb movements in sleep and wakefulness. Clin Neurophysiol 2007;118(9):1923- 1930. (Pubitemid 47187754)
42. Winkelman JW. The evoked heart rate response to periodic leg movements of sleep. Sleep 1999;22(5):575-580. (Pubitemid 29379114)
43. Lavigne GJ, Montplaisir JY. Restless legs syndrome and sleep bruxism: prevalence and association among Canadians. Sleep 1994;17(8):739-743.
44. Huynh N, Kato T, Rompre PH, et al. Sleep bruxism is associated to micro-arousals and an increase in cardiac sympathetic activity. J Sleep Res 2006;15(3):339-346. (Pubitemid 44215552)
45. Vetrugno R, Montagna P. Sleep-to-wake transition movement disorders. Sleep Med 2011;12(suppl 2):S11-S16.
46. Katzberg HD, Khan AH, So YT. Assessment: symptomatic treatment for muscle cramps (an evidence-based review): report of the therapeutics and technology assessment subcommittee of the American Academy of Neurology. Neurology 2010;74(8):691-696.